Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Skyfish to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Skyfish to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Penny Stocks To Watch: Why REVB, RVPH, BARK, and GRAY Stock Are Moving
-
Kuya Silver Announces Closing of $3.2 Million Private Placement Including Full Exercise of Agents' Option
-
Aytu BioScience (AYTU) Prices Public Offering of Common Stock, Warrants
-
Aytu BioPharma Announces Pricing of Public Offering
-
Marvel Biosciences Closes Second Tranche of Private Placement
-
FuelCell Energy CEO Jason Few to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
FuelCell Energy CEO Jason Few to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Iris Energy Announces Monthly Investor Update for July 2022
-
Iris Energy Announces Monthly Investor Update for July 2022
-
DraftKings Announces Jason Park’s Participation in Upcoming Event
-
DraftKings Announces Jason Park’s Participation in Upcoming Event
-
Form 8.3 - [Biffa plc - 08 08 2022] - (CGWL)
-
Aspen Aerogels to Participate in August Investor Conferences
-
PagerDuty to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Terns Pharmaceuticals Reports Second Quarter 2022 Financial Results and Corporate Highlights
-
Everbridge to Present at Canaccord Genuity Growth Conference
-
Laird Superfood to Participate in the Canaccord Genuity 42nd Annual Growth Conference
-
X4 Pharmaceuticals to Present at Canaccord Genuity’s 42nd Annual Growth Conference
-
Terns Pharmaceuticals Reports Second Quarter 2022 Financial Results and Corporate Highlights
-
Aytu BioScience (AYTU) Announces Public Offering
-
Cara Therapeutics Reports Second Quarter 2022 Financial Results
-
Cara Therapeutics Reports Second Quarter 2022 Financial Results
-
Aytu BioPharma Announces Launch of Public Offering
-
LSI Industries to Attend the 42nd Annual Canaccord Genuity Annual Growth Conference
-
Proactive news headlines including Tesla, Avalon GloboCare, Irwin Naturals, Japan Gold, Mountain Boy, VolitionRx
-
Proactive news headlines including Tesla, Avalon GloboCare, Irwin Naturals, Japan Gold, Mountain Boy, VolitionRx
-
Fluent, Inc. to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Proactive Group Holdings Inc. acquires online investor communications expert IRM
-
Proactive Group Holdings Inc. acquires online investor communications expert IRM
-
Mobivity to Present at Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022
-
Open Lending to Present at Canaccord Genuity 42nd Annual Growth Conference
-
Avalara Announces Second Quarter 2022 Financial Results
-
Rover to Present at the Canaccord Genuity Growth Conference on August 10, 2022
-
Rover to Present at the Canaccord Genuity Growth Conference on August 10, 2022
-
Ocuphire Pharma Announces Upcoming Presentations at Two Conferences in August
-
Form 8.3 - [Biffa plc - 05 08 2022] - (CGWL)
-
VAALCO Announces Board Approved Share Buy-Back Post Closing and Provides Update on Transformational Transaction
-
VAALCO Announces Board Approved Share Buy-Back Post Closing and Provides Update on Transformational Transaction
-
ICF to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
MicroStrategy to Present at Canaccord Genuity Growth Conference
-
InvestorNewsBreaks – Standard Lithium Ltd (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L) Announces Participation in Upcoming Canaccord Genuity Growth Conference
-
Qualtrics Executives to Participate in Upcoming Investor Conferences
-
AcuityAds to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
electroCore to Participate at Canaccord Genuity 42nd Annual Growth Conference
-
AcuityAds to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
UPDATE: Beyond Meat Inc. (BYND) PT Lowered to $30 at Canaccord Genuity
-
Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Insulet to Present at Upcoming Investor Conferences

